|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/33 | (2013.01) |
| C07K 14/33 | (2006.01) | ||
| A61K 38/48 | (2006.01) | ||
| C07K2319/55 | (2013.01) | ||
| C12N 5/00 | (2006.01) | ||
| A61K 38/00 | (2013.01) | ||
| C12N 9/52 | (2013.01) | ||
| C12Y 304/24069 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| A61P 1/04 | (2018.01) | ||
| A61P 1/14 | (2018.01) | ||
| A61P 1/18 | (2018.01) | ||
| A61P 13/10 | (2018.01) | ||
| A61P 17/00 | (2018.01) | ||
| A61P 17/06 | (2018.01) | ||
| A61P 21/00 | (2018.01) | ||
| A61P 25/00 | (2018.01) | ||
| A61P 25/04 | (2018.01) | ||
| A61P 25/14 | (2018.01) | ||
| A61P 25/28 | (2018.01) | ||
| A61P 27/02 | (2018.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61P 3/04 | (2018.01) | ||
| A61P 37/08 | (2018.01) | ||
| A61P 7/00 | (2018.01) |
| (11) | Number of the document | 3481852 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17742898.4 |
| Date of filing the European patent application | 2017-07-07 | |
| (97) | Date of publication of the European application | 2019-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2022-12-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/041255 |
| Date | 2017-07-07 |
| (87) | Number | WO 2018/009903 |
| Date | 2018-01-11 |
| (30) | Number | Date | Country code |
| 201662360239 P | 2016-07-08 | US |
| (72) |
STENMARK, Paul , SE
DONG, Min , US
ZHANG, Sicai , US
|
| (73) |
Children's Medical Center Corporation ,
55 Shattuck Street, Boston, MA 02115,
US
Stenmark, Paul , Svantearrheniusvag 16c, 10691 Stockholm, SE |
| (54) | A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES |
| A NOVEL BOTULINUM NEUROTOXIN AND ITS DERIVATIVES |